Wealth Plan Partners, LLC Zai Lab LTD Transaction History

Wealth Plan Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 16, 2023	SELL	$22.28 - $38.71 $3,342 - $5,806	-150 Reduced 0.38%	39,393 $1.5 Billion
Q3 2021 Dec 09, 2021	BUY	$105.0 - $178.37 $15,750 - $26,755	150 Added 0.38%	39,543 $4.17 Million
Q2 2020 Aug 19, 2020	SELL	$48.82 - $82.53 $3.69 Million - $6.23 Million	-75,500 Reduced 65.71%	39,393 $3.2 Million
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $234,600 - $377,400	-6,000 Reduced 4.96%	114,893 $7.41 Million
Q4 2019 Feb 14, 2020	SELL	$29.79 - $43.06 $1.01 Million - $1.46 Million	-34,000 Reduced 21.95%	120,893 $7.22 Million
Q2 2019 Aug 19, 2019	SELL	$25.73 - $35.79 $315,964 - $439,501	-12,280 Reduced 7.35%	154,893 $5.06 Million
Q1 2019 May 16, 2019	SELL	$21.71 - $31.54 $104,338 - $151,581	-4,806 Reduced 2.79%	167,173 $4.75 Million
Q4 2018 Feb 20, 2019	BUY	$14.95 - $24.72 $2.57 Million - $4.25 Million	171,979 New	171,979 $4.82 Million

146

53M

103K

439K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Plan Partners, LLC with notifications on news.